Pharma Guy

Supporters of the #Pharma & #Healthcare #Marketing Ecosystem. #Marketers, #Speakers, #Bloggers & #ThoughtLeaders welcome.

[Pharma Guy @pharmaguy]

24 sessions focused on agentic AI in pharma commercial.

Agentic Pharma Summit brings pharma leaders to Philadelphia Nov. 9 and 10, including keynote speaker Anna Berg Asberg of Gilead Sciences.

https://t.co/nHFAyV3Yt6

#AgenticAI #PharmaCommercial

[Pharma Guy @pharmaguy]

What happens when a key ad tech partner fails? For pharma marketers, understanding programmatic risk can help protect campaigns and media investments.

Read more: https://t.co/CkiYyABHRN

#PharmaMarketing #ProgrammaticAdvertising #AdTech

[Pharma Guy @pharmaguy]

Biosimilar adoption comes with a unique marketing challenge: standing out in an increasingly complex market.

The right strategy can help marketers navigate competition, strengthen confidence, and communicate meaningful value to key audiences.

Read more: https://t.co/g96bJRtJ5L

#PharmaMarketing #Biosimilars #PharmaStrategy #HealthcareMarketing

[Pharma Guy @pharmaguy]

Agentic Pharma Summit, Nov. 9 and 10, Philadelphia.

24 sessions on agentic AI in pharma commercial with leaders from Gilead, Pfizer, Sanofi, AstraZeneca and more.

https://t.co/nHFAyV3Yt6

#AgenticAI #PharmaMarketing

[Pharma Guy @pharmaguy]

As more biosimilars enter the market, strong marketing requires more than competing on price.

Clear education and credible messaging can help build confidence among HCPs and patients.

Read more: https://t.co/uEdIWLHBjs

#PharmaMarketing #Biosimilars #HealthcareMarketing

[Pharma Guy @pharmaguy]

Reality check from Ray Frost (Cogent Biosciences): first-to-market in rare disease ≠ easy. Payers still deny, physicians often don't know the disease state, and diagnosis alone can take up to 7 years. #lsproductlaunch

[Pharma Guy @pharmaguy]

Pharma trust is being measured differently.

Reputation still matters, but relevance and real-world impact are increasingly shaping how patients and HCPs view credibility.

Read more: https://t.co/uDAjEnoEUM

#PharmaMarketing #PharmaTrust #HealthcareMarketing #BrandStrategy

[Pharma Guy @pharmaguy]

"Launch Synchrony" — once you're in launch, you can only change so much. Lawrence Bressler (Chiesi) on why Commercial, Medical, and Access have to align 18–24 months before day one, not during it. #lsproductlaunch

[Pharma Guy @pharmaguy]

@FierceBiotech @FierceBiotech Encouraging progress in lupus research. Continued clinical development in complex autoimmune conditions highlights how the treatment landscape continues to evolve and expand.

[Pharma Guy @pharmaguy]

Rare disease launches live and die on the value story. Abeona's Madhav Vasanthavada: there are no pricing benchmarks for cell & gene therapy — you're building the evidence narrative from scratch. #lsproductlaunch

[Pharma Guy @pharmaguy]

Successful product launches are being built long before approval.

At the 2026 Life Sciences Product Launch Summit, industry leaders explored how global pricing pressures, Market Access, Medical Affairs, AI, and rare disease commercialization are changing what it takes to prepare for launch.

One message came through clearly: evidence generation, payer engagement, patient identification, and cross-functional alignment need to start earlier than ever.

Read our recap for key insights from the ACCESS track and what they could mean for the future of life sciences product launches.

Read the full article here: https://t.co/xDFuYAzCKU

#LifeSciences #Pharma #ProductLaunch #MarketAccess #MedicalAffairs #RareDisease #PharmaMarketing

[Pharma Guy @pharmaguy]

Trust in pharma is no longer built on brand recognition alone.

Transparency, clinical relevance, and measurable real-world impact are becoming stronger indicators of credibility with patients and HCPs.

Read more: https://t.co/QimFy8YGVD

#PharmaMarketing #PharmaTrust #BrandStrategy #HealthcareMarketing

[Pharma Guy @pharmaguy]

AI’s role in MLR may be less about replacing reviewers, and more about removing bottlenecks.

By supporting repetitive parts of the review process, machine learning could give teams more time to focus on the regulatory decisions that require human expertise.

Read more: https://t.co/JxNwV3xWJe

#PharmaMarketing #MLR #AIinPharma #RegulatoryAffairs

[Pharma Guy @pharmaguy]

@MMMnews @MMMnews Staying current with shifts across pharma and healthcare marketing is increasingly important as the landscape evolves. These developments can have meaningful implications for how brands approach engagement and communication.

[Pharma Guy @pharmaguy]

@PharmaMfg @PharmaMfg Partnerships across device development and manufacturing continue to shape how complex therapies move forward. Bringing specialized expertise together can be especially important as drug delivery approaches evolve.

[Pharma Guy @pharmaguy]

Can AI make MLR review faster without compromising compliance? Machine learning can help streamline repetitive tasks, but human oversight remains essential for regulatory judgment, accuracy, and accountability.

Read more: https://t.co/0WwGwnbrhp

#PharmaMarketing #MLR #PharmaCompliance #HealthcareAI

[FiercePharma @FiercePharma]

AstraZeneca snagged a recommendation from the CHMP, setting dual-binding nanobody C5 inhibitor Klygefa up for a formal approval in Europe. https://t.co/Eu0MXwevJO

[Pharma Guy @pharmaguy]

Voice search is changing how patients and HCPs find health information. Is pharma ready?

Discover how a voice-first strategy could shape the next digital shift in pharma.

Read more: https://t.co/6RsgdwwS4P

#PharmaMarketing #VoiceSearch #DigitalHealth #HealthcareMarketing

[Pharma Guy @pharmaguy]

Voice search is changing how patients and HCPs look for health information, favoring conversational questions and concise, direct answers.

For pharma marketers, adapting means creating content around how people naturally ask health questions while balancing clarity, accuracy, and compliance.

Read more: https://t.co/Ez1gsggGbU

#PharmaMarketing #VoiceSearch #DigitalHealth #HealthcareMarketing

[Pharma Guy @pharmaguy]

Virtual models. Real impact. 🧬

AI-powered digital twins are helping pharma accelerate drug discovery, optimize clinical development, enhance safety, and move toward more personalized medicine.

A smarter, more precise future for healthcare is taking shape.

Read more: Digital Twins, Real Patients: https://t.co/VQ8D0oGSY7

#DigitalTwins #PharmaInnovation #HealthcareAI #PrecisionMedicine #DigitalHealth